Reyou Ketamine, a New Jersey-based provider of ketamine and Spravato treatments for depression, opened a second clinic at 908 Oak Tree Road in South Plainfield as demand for mental health services continues to rise. The expansion is driven by rising demand for treatment-resistant depression, which affects an estimated 2.8 million Americans.
The clinic offers Spravato, an FDA-approved nasal spray form of ketamine, which is covered by most insurance plans including Horizon, Cigna, and Aetna. Unlike IV ketamine, which is typically not covered by insurance and can cost between $400 and $800 per session, Spravato is covered by most insurance plans when provided by certified clinics. Patients who have tried at least two antidepressants without adequate improvement may be eligible.
Reyou founder Michael Langer said many patients arrive after years of unsuccessful treatment for depression, anxiety, and PTSD. “People come to us after years of trying medications that didn’t work—they’re exhausted. They’ve lost hope,” Langer said. Reyou has delivered more than 8,000 treatments and pairs ketamine administration with guided support sessions during the neuroplasticity window that follows.
Langer emphasized that Reyou’s approach goes beyond administering medication. “We don’t do drive-through ketamine,” he said. “Reyou was built around what actually produces lasting results.” The expansion of the existing Howell location, which is consistently booked, reflects growing recognition of the effectiveness of ketamine-based treatments when other options fail. Reyou plans to open additional clinics by the end of 2026 and will host a grand opening event at its South Plainfield location in late April.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.mycentraljersey.com/story/money/business/2026/04/04/south-plainfield-ketamine-clinic-opens-to-treat-depression-ptsd/89405003007/